Microglial cell membrane-camouflaged nanoparticles for the treatment of ischemic stroke

Cheng Ruiqi; Zhang Rongrong; Qin Xinyue

doi:10.13406/j.cnki.cyxb.003540

您当前的位置：

首页 >

文章列表页 >

Microglial cell membrane-camouflaged nanoparticles for the treatment of ischemic stroke

Basic research | 更新时间：2025-10-21

- Microglial cell membrane-camouflaged nanoparticles for the treatment of ischemic stroke
- Journal of Chongqing Medical University Vol. 49, Issue 7, Pages: 853-858(2024)
- 作者机构：
  
  重庆医科大学附属第一医院神经内科，重庆 400016
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003540
  CLC： R743.3
- Received：18 January 2024，
  
  Revised：2024-04-23，
  
  Accepted：08 May 2024，
  
  Published：28 July 2024
- 稿件说明：
移动端阅览
成睿琪,张融融,秦新月.小胶质细胞膜伪装的纳米粒用于缺血性脑卒中的治疗[J].重庆医科大学学报,2024,49(7):853-858.

Cheng Ruiqi,Zhang Rongrong,Qin Xinyue.Microglial cell membrane-camouflaged nanoparticles for the treatment of ischemic stroke[J].Journal of Chongqing Medical University,2024,49(7):853-858.
成睿琪,张融融,秦新月.小胶质细胞膜伪装的纳米粒用于缺血性脑卒中的治疗[J].重庆医科大学学报,2024,49(7):853-858. DOI： 10.13406/j.cnki.cyxb.003540.

Cheng Ruiqi,Zhang Rongrong,Qin Xinyue.Microglial cell membrane-camouflaged nanoparticles for the treatment of ischemic stroke[J].Journal of Chongqing Medical University,2024,49(7):853-858. DOI： 10.13406/j.cnki.cyxb.003540.

摘要

目的

制备一款由小胶质细胞膜（microglia cell membrane，MiCM）伪装和装载相变材料全氟己烷（perfluorohexane，PFH）的多功能脂质体（liposome，Lipid）纳米粒（MiCM@PFH@Lipid），并研究其基本性质，检测特异性靶向卒中后的损伤部位和实现栓塞部位血管再通的能力。

方法

采用旋蒸法制备脂质体球载体，通过超声融合法将PFH和MiCM融合至脂质体形成MiCM@PFH@Lipid，透射电镜（transmission electron microscope，TEM）观察纳米粒的形样貌，马尔文粒径分析仪检测纳米粒第1天的粒径分布，和其在第1、3、5、7 d的电位分布，检测其稳定性。Western blot和考马斯亮蓝染色检测MiCM的包被情况，通过2，3，5－三苯基氯化四氮唑（2，3，5-triphenyltetrazolium chloride，TTC）、动物行为学测试检测小鼠脑功能状态。

结果

表征结果显示，MiCM@PFH@Lipid呈球形，粒径为（234.800±3.143） nm，平均电位为（-33.433±1.550） mV，具有良好的分散性，在7 d内具有较好的稳定性，MiCM成功包被在纳米粒上。小鼠离体荧光结果显示，纳米粒可以快速地在损伤部位蓄积，并且与非靶向组比较差异有统计学意义（

0.05）。动物行为学实验和脑TTC染色结果显示，MiCM@PFH@Lipid纳米粒可以实现血管再通，恢复部分神经功能（

0.05）。病理学检查显示，纳米粒治疗后没有对重要脏器造成明显损伤，而血常规检测与正常对照组并未见明显异常（

0.05）。

结论

本实验成功制备了多功能纳米粒MiCM@PFH@Lipid，其可以靶向至缺血性卒中后脑损伤区域并破坏血栓，用于缺血性卒中疾病的治疗。

Abstract

Objective

To prepare MiCM@PFH@Lipid，a multifunctional liposome（Lipid） nanoparticles camouflaged with microglial cell membrane（MiCM） and loaded with the phase change material Perfluorohexane（PFH），to study its basic properties，and to test its ability to specifically target the site of injury after stroke and to achieve revascularization at the site of thrombus.

Methods

Liposome sphere carriers were prepared by rotary evaporation method. MiCM and PFH were fused with the liposome to form MiCM@PFH@Lipid using the ultrasonic fusion method. Transmission electron microscopy was used to observe the morphology of the nanoparticles. The particle size distribution of nanoparticles at day 1 and their potential distribution at days 1，3，5，and 7 were measured using a Malvern particle size analyzer to detect their stability. Western blot and Coomassie brilliant blue staining were used to detect the encapsulation of nanoparticles with MiCM. The functional state of the mouse brain was detected using brain staining with 2，3，5-triphenyltetrazolium chloride and animal behavior test.

Results

MiCM@PFH@Lipid nanoparticles were spherical in shape，with a particle size of （234.800±3.143） nm and an average potential of （-33.433±1.550） mV. The nanoparticles were well dispersed and stable within 7 days. MiCM was successfully encapsulated on the nanoparticles. Mouse ex vivo fluorescence image showed that the nanoparticles could rapidly accumulate at the site of injury，which was significantly different as compared with the non-targeted group（

0.05）. Animal behavior test and brain staining showed that MiCM@PFH@Lipid nanoparticles could achieve vascular recanalization and partly restore neurological functions（

0.05）. Pathological examination showed that there was no significant damage to important organs after nanoparticle treatment. Routine blood test showed no significant abnormality as compared with the normal control group（

0.05）.

Conclusion

In this study，multifunctional nanoparticles（MiCM@PFH@Lipid） were successfully prepared. These nanoparticles can target the injured brain area after ischemic stroke and destroy thrombus，and thus can be used for the treatment of ischemic stroke.

关键词

Keywords

references

Ding QQ ， Liu SW ， Yao YD ， et al . Global，regional，and national burden of ischemic stroke，1990-2019 [J ] . Neurology ， 2022 ， 98 （ 3 ）： e279 - e290 ．

GBD Stroke Collaborators . Global，regional，and national burden of stroke and its risk factors，1990-2019：a systematic analysis for the Global Burden of Disease Study 2019 [J ] . Lancet Neurol ， 2021 ， 20 （ 10 ）： 795 - 820 ．

Jahan R ， Saver JL ， Schwamm LH ， et al . Association between time to treatment with endovascular reperfusion therapy and outcomes in patients with acute ischemic stroke treated in clinical practice [J ] . JAMA ， 2019 ， 322 （ 3 ）： 252 - 263 ．

Rajendran R ， Kunnil A ， Radhakrishnan A ， et al . Current trends and future perspectives for enhanced drug delivery to central nervous system in treatment of stroke [J ] . Ther Deliv ， 2023 ， 14 （ 1 ）： 61 - 85 ．

Huang Y ， Li M ， Li JY ， et al . The efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA：a systematic review [J ] . PLoS One ， 2013 ， 8 （ 6 ）： e65754 ．

Crispo JAG ， Thibault DP ， Fortin Y ， et al . Association between medication-related adverse events and non-elective readmission in acute ischemic stroke [J ] . BMC Neurol ， 2018 ， 18 （ 1 ）： 192 ．

Teleanu DM ， Chircov C ， Grumezescu AM ， et al . Neuronanomedicine：an up-to-date overview [J ] . Pharmaceutics ， 2019 ， 11 （ 3 ）： 101 ．

Sych T ， Levental KR ， Sezgin E . Lipid-protein interactions in plasma membrane organization and function [J ] . Annu Rev Biophys ， 2022 ， 51 ： 135 - 156 ．

Go YK ， Leal C . Polymer-lipid hybrid materials [J ] . Chem Rev ， 2021 ， 121 （ 22 ）： 13996 - 14030 ．

Qin C ， Zhou LQ ， Ma XT ， et al . Dual functions of microglia in ischemic stroke [J ] . Neurosci Bull ， 2019 ， 35 （ 5 ）： 921 - 933 ．

Haynes SE ， Hollopeter G ， Yang G ， et al . The P2Y12 receptor regulates microglial activation by extracellular nucleotides [J ] . Nat Neurosci ， 2006 ， 9 （ 12 ）： 1512 - 1519 ．

Lou NH ， Takano T ， Pei Y ， et al . Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier [J ] . Proc Natl Acad Sci USA ， 2016 ， 113 （ 4 ）： 1074 - 1079 ．

Zhong YX ， Zhang Y ， Xu J ， et al . Low-intensity focused ultrasound-responsive phase-transitional nanoparticles for thrombolysis without vascular damage：a synergistic nonpharmaceutical strategy [J ] . ACS Nano ， 2019 ， 13 （ 3 ）： 3387 - 3403 ．

Ricci S ， Dinia L ， Del Sette M ， et al . Sonothrombolysis for acute ischaemic stroke [J ] . Cochrane Database Syst Rev ， 2012 ，10：CD008348．

Wu HH ， Jiang XC ， Li YS ， et al . Engineering stem cell derived biomimetic vesicles for versatility and effective targeted delivery [J ] . Adv Funct Materials ， 2020 ， 30 （ 49 ）： 2006169 ．

Jin R ， Zhu XL ， Li GH . Embolic middle cerebral artery occlusion（MCAO） for ischemic stroke with homologous blood clots in rats [J ] . J Vis Exp ， 2014 （ 91 ）： 51956 ．

Ruan JS ， Yao Y . Behavioral tests in rodent models of stroke [J ] . Brain Hemorrhages ， 2020 ， 1 （ 4 ）： 171 - 184 ．

Nisar T ， Hanumanthu R ， Khandelwal P . Symptomatic intracerebral hemorrhage after intravenous thrombolysis：predictive factors and validation of prediction models [J ] . J Stroke Cerebrovasc Dis ， 2019 ， 28 （ 11 ）： 104360 ．

Sercombe L ， Veerati T ， Moheimani F ， et al . Advances and challenges of liposome assisted drug delivery [J ] . Front Pharmacol ， 2015 ， 6 ： 286 ．

Camacho-Hernández NP ， Peña-Ortega F . Fractalkine/CX3CR1-dependent modulation of synaptic and network plasticity in health and disease [J ] . Neural Plast ， 2023 ， 2023 ： 4637073 ．

Paul S ， Candelario-Jalil E . Emerging neuroprotective strategies for the treatment of ischemic stroke：an overview of clinical and preclinical studies [J ] . Exp Neurol ， 2021 ， 335 ： 113518 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research advances in the mechanism of action of Chinese herbal monomer extract in the treatment of ischemic stroke

Effects of M1 microglia-derived exosomes on the function of the blood-brain barrier

Research advances in the effect of exosomes and their microRNAs on cerebral ischemia-reperfusion injury

Effect evaluation of BTS quality improvement model in patients with ischemic stroke

Research advances in traditional Chinese medicine for treating ischemic stroke by regulating the hypoxia-inducible factor 1α signaling pathway

Related Author

Ding Hongzhi

Yi Junwen

Chen Jiaxin

Luo Jia

Qin Xue

Wei Lili

Deng Qionghua

Jiang Wen

Related Institution

Shihezi University School of Medicine

Department of Cardiovascular Surgery,the First Affiliated Hospital of Kunming Medical University

Department of Neurology,the First Affiliated Hospital of Kunming Medical University

Department of Anesthesiology，The First Affiliated Hospital of Kunming Medical University

School of Nursing，Fudan University

⁰